- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 279/10 - Thiazines-1, 4Thiazines-1, 4 hydrogénées
Détention brevets de la classe C07D 279/10
Brevets de cette classe: 21
Historique des publications depuis 10 ans
|
0
|
1
|
0
|
0
|
3
|
0
|
0
|
0
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Abbvie Inc. | 1837 |
2 |
| Bristol-myers Squibb Company | 4789 |
1 |
| F. Hoffmann-La Roche AG | 7847 |
1 |
| Hoffmann-La Roche Inc. | 3726 |
1 |
| The Regents of the University of California | 20590 |
1 |
| Boehringer Ingelheim International GmbH | 4494 |
1 |
| Janssen Pharmaceutica N.V. | 3213 |
1 |
| Merck Patent GmbH | 5669 |
1 |
| FUJIFILM Corporation | 30327 |
1 |
| Ardelyx, Inc. | 115 |
1 |
| Icahn School of Medicine at Mount Sinai | 1009 |
1 |
| Jinan University | 252 |
1 |
| MSD Italia S.r.l. | 51 |
1 |
| Nanyang Technological University | 2171 |
1 |
| National University of Singapore | 2565 |
1 |
| OSI Pharmaceuticals, LLC | 49 |
1 |
| Poniard Pharmaceuticals, Inc. | 18 |
1 |
| XOMA (US) LLC | 72 |
1 |
| Theravance Biopharma R&D IP, LLC | 416 |
1 |
| Federal State Unitary Enterprise "all-russian Research Institute of Automatics" (fsue "vniia") | 3 |
1 |
| Autres propriétaires | 0 |